Advertisement
Canada markets open in 3 hours 28 minutes
  • S&P/TSX

    22,375.83
    +116.63 (+0.52%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • DOW

    39,387.76
    +331.36 (+0.85%)
     
  • CAD/USD

    0.7308
    -0.0003 (-0.05%)
     
  • CRUDE OIL

    79.76
    +0.50 (+0.63%)
     
  • Bitcoin CAD

    86,366.84
    +2,546.86 (+3.04%)
     
  • CMC Crypto 200

    1,306.76
    -51.25 (-3.77%)
     
  • GOLD FUTURES

    2,377.40
    +37.10 (+1.59%)
     
  • RUSSELL 2000

    2,073.63
    +18.49 (+0.90%)
     
  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     
  • NASDAQ futures

    18,302.00
    +87.50 (+0.48%)
     
  • VOLATILITY

    12.80
    +0.11 (+0.87%)
     
  • FTSE

    8,449.04
    +67.69 (+0.81%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6778
    0.0000 (0.00%)
     

Revisiting Valuation Multiples for Cannabis Companies

Revisiting Valuation Multiples for Cannabis Companies

Recreational cannabis is just a few months away from being legalized in Canada, and producers (HMMJ) are running at full bore to capture a piece of the market. Let’s revisit the valuation multiples of the most active cannabis players. Looking at the median of only Canadian cannabis producers—including Canopy Growth (WEED), Aurora Cannabis (ACB), MedReleaf (MEDFF), Cronos (CRON), and others mentioned in the chart—we see a similar trend.